In conclusion, we showed that Nestin silencing significantly reduced the growth and invasion of endometrial cancer cells through the suppression of the TGF-β signaling pathway, which is activated in endometrial tumors and is implicated in the EMT process. The gene discussed is TGFB1; the disease is endometrium neoplasm.